On his blog, DrugMonkey discusses the argument that junior reviewers become bogged down in the details in study sections and don't focus on the quality of the science. DrugMonkey says some of these complaints may be due to how less established scientists think or are taught study sections and reviews should go, based upon the feedback they have themselves received.